Close

Eagle Pharma (EGRX) Commences Rolling Submission of Ryanodex NDA as EHS Treatment

Go back to Eagle Pharma (EGRX) Commences Rolling Submission of Ryanodex NDA as EHS Treatment
EAGLE PHARMACEUT (NASDAQ: EGRX) Delayed: 5.24 +0.23 (4.59%)
Previous Close $5.01    52 Week High $102.48 
Open $4.96    52 Week Low $33.02 
Day High $5.37    P/E N/A 
Day Low $4.96    EPS $-1.02 
Volume 80,453